Pfizer ‘ready to roll’ if BioNTech COVID-19 shot is approvedPfizer now has hundreds of thousands of doses of BioNTech’s COVID-19 vaccine coming off the production line at Share XPfizer ‘ready to roll’ if BioNTech COVID-19 shot is approvedhttps://pharmaphorum.com/news/pfizer-ready-to-roll-if-biontech-covid-19-shot-is-approved/
UK government signs contract for COVID-19 challenge trialThe UK government has signed a contract to develop a controversial COVID-19 human challenge trial, where participants will Share XUK government signs contract for COVID-19 challenge trialhttps://pharmaphorum.com/news/uk-government-signs-contract-for-covid-19-challenge-trial/
Pfizer to wait until after election to file COVID-19 vaccine in USPfizer said it will wait until after the US election to file its COVID-19 vaccine with the US Share XPfizer to wait until after election to file COVID-19 vaccine in UShttps://pharmaphorum.com/news/pfizer-to-wait-until-after-election-to-file-covid-19-vaccine-in-us/
Race for COVID-19 vaccine hots up as EMA begins review of BioNTech/Pfizer jabThe European Medicines Agency has begun a second “rolling review” of a potential coronavirus vaccine jointly developed by Share XRace for COVID-19 vaccine hots up as EMA begins review of BioNTech/Pfizer jabhttps://pharmaphorum.com/news/ema-begins-rolling-review-biontech-pfizers-covid-19-shot/
Political interference fears mount as Trump backs Pfizer’s COVID vaccinePresident Donald Trump has suggested that Pfizer could be first to secure the first approval of a COVID-19 Share XPolitical interference fears mount as Trump backs Pfizer’s COVID vaccinehttps://pharmaphorum.com/news/political-interference-fears-mount-as-trump-backs-pfizers-covid-vaccine/
BioNTech, Lilly shore up manufacturing capacity for their COVID-19 medsWith vaccines and drugs for COVID-19 now in late-stage development, companies are moving swiftly to lay down the Share XBioNTech, Lilly shore up manufacturing capacity for their COVID-19 medshttps://pharmaphorum.com/news/biontech-lilly-shore-up-manufacturing-capacity-for-their-covid-19-meds/
BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fundIn May, Germany pledged to provide up to €750 million ($889 million) in funding to support vaccines against Share XBioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fundhttps://pharmaphorum.com/news/biontech-curevac-claim-bulk-of-germanys-e750m-covid-19-vaccines-fund/
AZ halts COVID-19 vaccine after safety scare, as UK faces ‘second wave’It’s a bleak day in the fight against COVID-19, after the UK banned social gatherings of more than Share XAZ halts COVID-19 vaccine after safety scare, as UK faces ‘second wave’https://pharmaphorum.com/news/az-halts-covid-19-vaccine-after-safety-scare-as-uk-faces-second-wave/
Coronavirus pharma news round-up 21/08/20New insights into smell and taste loss symptoms, artificial intelligence and further encouraging data from a vaccine candidate Share XCoronavirus pharma news round-up 21/08/20https://pharmaphorum.com/views-and-analysis/coronavirus-pharma-news-round-up-21-08-20/
